Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-370-9 | CAS number: 85480-89-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was well documented and meets generally accepted scientific principles, and conducted in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
- Principles of method if other than guideline:
- the study design of i.v.dosing studies in rats and mice to examine the absorption, tissue distribution, metabolism and excretion and retention of the test compound. A total of 20 male rats and male mice were used, with 4 from each group sacrificed at 6, 24 and 96 hr and 14 and 28 days following dosing. Excreta were sampled at 8, 24,48,72,96 and 168 hours following dosing. At sacrifice tissues and organs were analysed for 14C content.
- GLP compliance:
- yes
Test material
- Reference substance name:
- [ethylenebis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt
- EC Number:
- 244-742-5
- EC Name:
- [ethylenebis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt
- Cas Number:
- 22036-77-7
- IUPAC Name:
- 22036-77-7
- Details on test material:
- Non labelled EDITEMPA (Dequest 20419) - Lot nr 176-40-4) with chemical purity of 99%.
14C labelled EDITEMPA , with radiochemical purity ranging from 92-93%.. The 14C compound had a purity ranging from 96.4 - 99 %.
The compound was dissolved in sodium hydroxide solution and if necessary the pH was adjusted to ca 7. The doses administered via IV to rats at a volume of 4 ml/kg, and in mice at a volume of 20 ml/kg via the tail vein.
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- other: Rat (Sprague Dawley) and mice (B6C3F1)
- Strain:
- other: Sprague Dawley rats and B6C3F1 mice
- Sex:
- male
Administration / exposure
- Route of administration:
- intravenous
- Vehicle:
- unchanged (no vehicle)
- Duration and frequency of treatment / exposure:
- A total of 20 male rats and male mice were used, with 4 from each group sacrificed at 6, 24 and 96 hr and 14 and 28 days following dosing. Excreta were sampled at 8, 24,48,72,96 and 168 hours following dosing. At sacrifice tissues and organs were analysed for 14C content.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
15 mg/kg
- No. of animals per sex per dose / concentration:
- Only males used.
- Control animals:
- no
Results and discussion
- Preliminary studies:
- Following iv administration (15 mg/kg) to rats the compound disappeared from the blood rapidly. In 2 hours only 0.4% of the dose was recovered in blood. After which 14C disapperared slowly. The distribtion t1/2 was 14 mins while the elimiation t1/2 was 67 hours. Eliimination of 14C in urine was rapid, by 8 hours 56% of the dose was excreted by this route, 12% between 8 -168 hours. Excretion in faeces was limited to 7% of the dose in 168 hours. Recovery of 14C in tissue was low even at early 6 hour sacrifice times. The spleen, bone marrow and kidneys showed higher uptake of radioactivity.
In mice elimination of 14C in urine was seen as 56% of dose eliminated by 24 hours and an additional 16% by 168 hours. Only 3% via the faeces in 168 vs 7 % in rats, suggesting a lower elimination by the biliary/intestinal routes in mice. Recovery of 14C was very low even at early times and only spleen and kidneys showed significant uptake of radioactivity.
Rats- most of administered radioactivity was recovered in bone, 55% of dose at 6hr declining to 21% by 28 days post dosing. Disappearance of EDITEMPA from the bone occurred slowly (t ½ of 20 days). The trabecular bone showed the higher 14C level than cortical bone, with disappearance from the latter occuring at a slower rate.
For mice 35% of the administered dose was recovered in bone at 6 hours, which decreased to 19% at 28 days. EDITEMAP disappeared from the bone of mice with a t ½ of 26 days. The AUC was 1393 micrograms/g. day in mice compared to 1903 micrograms/g. day in rats. The average level of EDITEMPA in bone was higher in rats than mice.
HPLC analysis of excreta indicated the presence of impurities in the sample and the increased amounts in the ecreta is probably due to preferential uptake of EDITEMPA by the bone.
In summary, these studies show that EDITEMPA has a high affinity for bone. The disappearance of 14C from bone is slow, as demonstrated by the long t ½ of 20 days (rats) and 26 days (mice). Data suggests that EDITEMPA is not metabolised to any great extent. The disposition in both mice and rats is similar. Although the levels of 14C in rats and mice were slightly different they probably do not account for any differences in biological response.
Applicant's summary and conclusion
- Conclusions:
- In summary, these studies show that following iv administration (15 mg/kg) to rats, EDITEMPA has a high affinity for bone. The disappearance of 14C from bone is slow, as demonstrated by the long t ½ of 20 days (rats) and 26 days (mice). Data suggests that EDITEMPA is not metabolised to any great extent. The disposition in both mice and rats is similar. Although the levels of 14C in rats and mice were slightly different they probably do not account for any differences in biological response.
- Executive summary:
A total of 20 male rats and male mice were used, with 4 from each group sacrificed at 6, 24 and 96 hr and 14 and 28 days following IV dosing (15 mg/kg). Excreta were sampled at 8, 24, 48, 72, 96 and 168 hours following dosing. At sacrifice tissues and organs were analysed for 14C content. These studies show that EDITEMPA has a high affinity for bone. The disappearance of 14C from bone is slow, as demonstrated by the long t ½ of 20 days (rats) and 26 days (mice). Data suggests that EDITEMPA is not metabolised to any great extent. The disposition in both mice and rats is similar. Although the levels of 14C in rats and mice were slightly different they probably do not account for any differences in biological response.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
